Key result
Primary percutaneous coronary intervention in STEMI patients showed that age ≥75 years was not an independent predictor of 30-day mortality (OR 1.00; 95% CI 0.41-2.41; P=0.99).
Why the study?
Does successful primary percutaneous coronary intervention improve 30-day mortality in elderly patients (≥75 years) with STEMI compared to unsuccessful PCI and younger patients?
Population
947 consecutive patients with ST-segment elevation myocardial infarction treated with primary percutaneous…
Comparison
Primary percutaneous coronary intervention with… vs Younger patients treated with primary PCI, and…
Design
Cohort
Follow-up
30-day
Authors
Loading...
Supports primary PCI in elderly STEMI without independent age-related mortality risk; leaves open randomized confirmation of reperfusion benefits.
Cohort (n=947)
Does successful primary percutaneous coronary intervention improve 30-day mortality in elderly patients (≥75 years) with STEMI compared to unsuccessful PCI and younger patients?
Absolute Event Rate: 7.6% vs 3.9%
p-value: p=0.015
Successful primary PCI significantly reduces 30-day mortality in STEMI patients aged ≥75 years, with outcomes comparable to younger patients when reperfusion is successful.
Sakai et al. (2011) conducted a cohort in ST-segment elevation myocardial infarction (STEMI) (n=947). Primary percutaneous coronary intervention vs. Age <75 years was evaluated on 30-day mortality (p=0.015). Primary percutaneous coronary intervention in STEMI patients showed that age ≥75 years was not an independent predictor of 30-day mortality (OR 1.00; 95% CI 0.41-2.41; P=0.99).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: